Brown-Forman Corporation (BF.B - Free Report) , the world’s leading producer and distributor of premium alcoholic beverages, came out with first-quarter fiscal 2017 results, wherein adjusted earnings of 36 cents a share missed the Zacks Consensus Estimate by a penny, and also decreased 2.7% year over year.
The company reiterated its fiscal 2017 outlook. For fiscal 2017, management expects a 4%-6% increase in underlying sales. Further, underlying operating income is anticipated to increase in a range of 7%–9%. Based on the aforementioned estimates and a $0.03 negative influence from foreign currency headwinds, the company projects fiscal 2017 earnings in the range of $1.71–$1.81 per share.
Earnings Estimate Revision: The Zacks Consensus Estimate for fiscal 2017 has been unchanged in the last 30 days. In the trailing four quarters, excluding quarter under review, the company outperformed the Zacks Consensus Estimate by an average of 3.7%.
Revenues: Net sales declined 5% year over year to $661 million, after deducting excise taxes. However, on an underlying basis (excluding negative currency impact and other adjustments), sales grew 2%. Moreover, the company’s sales, before accounting for excise taxes, came in at $856 million, down 5% from the prior-year figure of $900 million. The Zacks Consensus Estimate was pegged at $675.7 million.
Key Events: The company repurchased 4.2 million shares worth $201 million during the first three months of fiscal 2017, leaving shares worth $690 million remaining under its buyback authorization, as of Jul 31. On Aug 18, 2016, the company executed a two-for-one stock split.
Zacks Rank: Currently, Brown-Forman carries a Zacks Rank #4 (Sell) which is subject to change following the earnings announcement.
Stock Movement: Brown-Forman’s shares declined nearly 5% during pre-market trading hours following the earnings release.
Check back later for our full write up on Brown-Forman’s earnings report!
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Brown-Forman Corporation (BF.B - Free Report) , the world’s leading producer and distributor of premium alcoholic beverages, came out with first-quarter fiscal 2017 results, wherein adjusted earnings of 36 cents a share missed the Zacks Consensus Estimate by a penny, and also decreased 2.7% year over year.
The company reiterated its fiscal 2017 outlook. For fiscal 2017, management expects a 4%-6% increase in underlying sales. Further, underlying operating income is anticipated to increase in a range of 7%–9%. Based on the aforementioned estimates and a $0.03 negative influence from foreign currency headwinds, the company projects fiscal 2017 earnings in the range of $1.71–$1.81 per share.
Earnings Estimate Revision: The Zacks Consensus Estimate for fiscal 2017 has been unchanged in the last 30 days. In the trailing four quarters, excluding quarter under review, the company outperformed the Zacks Consensus Estimate by an average of 3.7%.
Revenues: Net sales declined 5% year over year to $661 million, after deducting excise taxes. However, on an underlying basis (excluding negative currency impact and other adjustments), sales grew 2%. Moreover, the company’s sales, before accounting for excise taxes, came in at $856 million, down 5% from the prior-year figure of $900 million. The Zacks Consensus Estimate was pegged at $675.7 million.
Key Events: The company repurchased 4.2 million shares worth $201 million during the first three months of fiscal 2017, leaving shares worth $690 million remaining under its buyback authorization, as of Jul 31. On Aug 18, 2016, the company executed a two-for-one stock split.
Zacks Rank: Currently, Brown-Forman carries a Zacks Rank #4 (Sell) which is subject to change following the earnings announcement.
Stock Movement: Brown-Forman’s shares declined nearly 5% during pre-market trading hours following the earnings release.
Check back later for our full write up on Brown-Forman’s earnings report!
Confidential from Zacks
Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BF.B - FREE